This inventor holds 1 USPTO granted patent. Top assignee: Nihon Medi-Physics Company, Limited. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Atsuo Waki: Diagnostic Innovation in Tumor Cell Research
Introduction
Atsuo Waki is an inventor associated with Fukui, Japan, and Nihon Medi-Physics Company, Limited. His patent work concerns diagnostic agents for assessing glycometabolic function, including methods for diagnosing the pathological state of tumor cells. The available information identifies 1 patent associated with him.
Latest Patents
Waki’s listed patent, “Method of Diagnosing Pathological State of Tumor Cells Using a…,” describes a diagnostic agent containing a glucose derivative. The compound includes specified acyl groups and a radioisotope of a halogen, attached directly or through a chemical group. The invention focuses on using this agent to evaluate glycometabolic function and support the diagnosis of tumor-cell conditions.
Career Highlights
Waki’s documented patent activity reflects work at the intersection of diagnostic chemistry and medical imaging. The patent’s use of a radioisotope-labeled glucose derivative illustrates an approach to investigating tumor cells through their metabolic behavior.
Collaborations
Yasuhisa Fujibayashi and Akira Yokoyama are identified as Waki’s coworkers. Their association provides context for the collaborative research environment connected with his patent work.
Conclusion
Atsuo Waki’s recorded invention centers on a radioisotope-containing glucose derivative for diagnosing tumor-cell conditions, highlighting the role of metabolic diagnostics in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile